Biolegend, 115521, Alexa Fluor® 488 anti-mouse CD19 Antibody
100microg
Catalog Number: 115521
Send an RFQ.
Category
| Verified Reactivity | Mouse |
|---|---|
| Antibody Type | Monoclonal |
| Host Species | Rat |
| Immunogen | Mouse CD19-expressing K562 human erythroleukemia cells |
| Formulation | Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide. |
| Preparation | The antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 488 under optimal conditions. |
| Concentration | 0.5 mg/ml |
| Storage & Handling | The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze. |
| Application | FC - Quality tested |
| Recommended Usage | Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.* Alexa Fluor® 488 has a maximum emission of 519 nm when it is excited at 488 nm.Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.View full statement regarding label licenses |
| Excitation Laser | Blue Laser (488 nm) |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
| Application Notes | Additional reported applications (for the relevant formats) include: immunofluorescence7. |
|---|
| Application References(PubMed link indicates BioLegend citation) | Shoham T, et al. 2003. J. Immunol. 171:4062. (FC) Goodyear CS, et al. 2004. J. Immunol. 172:2870. (FC) Kamimura D, et al. 2006. J. Immunol. 177:306. (FC) Andoniou CE, et al. 2005. Nat. Immunol. 6:1011. (FC) Lawson BR, et al. 2007. J. Immunol. 178:5366. (FC) Phan TG, et al. 2007. Nat. Immunol. 8:992. (FC) Hayashida K, et al. 2008. J. Biol. Chem. 283:19895. (IF) PubMed Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed Stadnisky MD, et al. 2011. Blood. 117:5133. (FC) PubMed Perlot T, et al. 2012. J. Immunol. 188:1201. (FC) PubMed Olive V, et al. 2013. Elife. 2:822. PubMed Miyai T, et al. 2014. PNAS. 111:11780. PubMed |
|---|
| Product Citations | Harsha Krovi S, et al. 2020. Nat Commun. 4.790277778. PubMed Arora S, et al. 2023. PLoS One. 18:e0286211. PubMed Jang HJ, et al. 2022. Cancer Res. 82:2593. PubMed Okajima T, et al. 2021. Front Immunol. 12:738041. PubMed Chow MT et al. 2019. Immunity. 50(6):1498-1512 . PubMed Logan C, Bowen C, and Menko A 2017. Sci Rep. . 10.1038/s41598-017-16456-5. PubMed Shan M et al. 2018. Immunity. 49(4):709-724 . PubMed Chen C, et al. 2019. Cell Rep. 29:4200. PubMed Loh Z, et al. 2020. PLOS Pathogens. 16(7):e1008651. PubMed Wittner J, et al. 2022. Mucosal Immunol. 15:668. PubMed Hu M, et al. 2020. Cancer Immunol Res. 8:1150. PubMed Collado J, et al. 2013. Eur J Immunol. 43:2273. PubMed Wang J, et al. 2011. Am J Pathol. 178:2168. PubMed Zhu K, et al. 2022. EMBO Rep. 23:e54499. PubMed Shimba A et al. 2018. Immunity. 48(2):286-298 . PubMed Seeley-Fallen M, et al. 2014. Proc Natl Acad Sci U S A. 111:9881. PubMed Alterauge D, et al. 2020. Cell Rep. 33:108232. PubMed Das A, et al. 2020. J Bone Miner Res. 36:199. PubMed Henkle TR, et al. 2021. Cancer Res. 81:4560. PubMed Song W, et al. 2022. Immunity. 55:290. PubMed |
|---|
| RRID | AB_493339 (BioLegend Cat. No. 115524) AB_389307 (BioLegend Cat. No. 115521) |
|---|
| Structure | Ig superfamily, associates with CD21 and CD81, 95 kD |
|---|
| Distribution | Pro-B cells to mature B cells (during development), follicular dendritic cells |
|---|
| Function | Modulates B cell activation and differentiation |
|---|
| Ligand/Receptor | CD21, CD81, Leu-13 |
|---|
| Cell Type | B cells, Dendritic cells |
|---|
| Biology Area | Costimulatory Molecules, Immunology |
|---|
| Molecular Family | CD Molecules |
|---|
| Antigen References | 1. Fearon DT. 1993. Curr. Opin. Immunol. 5:341. 2. Krop I, et al. 1996. Eur. J. Immunol. 26:238. 3. Krop I, et al. 1996. J. Immunol. 157:48. 4. Tedder TF, et al. 1994. Immunol. Today 15:437. |
|---|
| Gene ID | 12478 |
|---|
| UniProt | View information about CD19 on UniProt.org |
|---|
| Clone | 6D5 |
|---|
| Regulatory Status | RUO |
|---|
| Other Names | B4 |
|---|
| Isotype | Rat IgG2a, κ |
|---|